Jeremy Wyatt, CEO, Ametris, discusses how operational best practices for integrating wearables into oncology trials center on minimizing patient burden through thoughtful workflow design, careful ...

Charlie Paterson, partner at PA Consulting, explains how mixed signals on FDA risk tolerance are accelerating the ...

As clinical trials grow more global and complex, AI is emerging as a practical enabler of smarter financial management by automating manual processes, improving visibility across fragmented systems, ...

Miriam Dervan, founder & CEO of mdgroup, explains how treating patient experience as a strategic investment—rather than a ...

Mike Wenger, chief innovation officer at CRIO, discusses how different site types—from academic medical centers to ...

Sustained “boots-on-the-ground” community engagement, beyond digital recruitment campaigns, was positioned as a primary lever to improve trial equity and representation. Hesitancy to discuss diversity ...

Holly Leslie, vice president of services at Ledger Run, explains why site selectivity is not yet universal, but increasingly ...

Otis Johnson, PhD, MPA, founder and principal consultant at Vantix Operations, discusses how ESG is evolving from a reporting ...

Charlie Paterson, partner at PA Consulting, outlines how limited FDA guidance on innovative designs, decentralized models, ...

Mike Wenger, chief innovation officer at CRIO, discusses how different site types—from academic medical centers to independent research sites—require distinct eSource approaches, and why aligning ...

Efficiency and accelerating clinical trial timelines have emerged as key themes at this year’s annual SCOPE Summit in Orlando, FL. The opening keynote panel of the event moderated by Jeremy Goldberg, ...

Getz K, Barr E. Aligning Purpose, Innovation, and Operational Excellence in Clinical Development. SCOPE Summit 2026. February 3, 2026. Stay current in clinical research with Applied Clinical Trials, ...